RXRX

Recursion Pharmaceuticals, Inc.

Insider Trades

ActorHolding ValueLast TransactionAmountTransaction PriceCurrent Price
Gibson ChristopherDirector
--40k shares
Grant / ExerciseJun 5, 2026
Disclosure amount unavailable40k shares
--
$3.17
Gibson ChristopherDirector
--40k shares
SellJun 5, 2026
$144.8K40k shares
$3.62
$3.17
Khan NajatDirector, Officer: CEO And President
--23.6k shares
SellJun 5, 2026
$84.5K23.6k shares
$3.58
$3.17
Gibson ChristopherDirector
--40k shares
Grant / ExerciseMay 22, 2026
Disclosure amount unavailable40k shares
--
$3.17
Gibson ChristopherDirector
--40k shares
SellMay 22, 2026
$123.2K40k shares
$3.08
$3.17

News

zacks.comRecursion Pharmaceuticals (RXRX) Up 16.2% Since Last Earnings Report: Can It Continue?zacks.comJun 5fool.comRecursion Pharmaceuticals vs. Schrödinger: Which Healthcare Stock Is a Better Buy in 2026?fool.comJun 2globenewswire.comRecursion to Participate in Upcoming Investor Conferencesglobenewswire.comJun 2globenewswire.comRecursion Reports Grant of Inducement Awards as Permitted by the Nasdaq Listing Rulesglobenewswire.comMay 29globenewswire.comAltitude Lab Portfolio Companies Surpass $205 Million in Funding, Marking a New Era for Early-Stage Biotechs in Salt Lake Cityglobenewswire.comMay 19